Clinical trial

Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)

NCT00000379 · Boston University, Other · Completed

Key facts

NCT number NCT00000379
Title Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
Official title Treatment of Outcomes of Fluoxetine vs EMDR in PTSD
Lead sponsor Boston University, Other
Collaborators National Institute of Mental Health (NIMH) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Stress Disorders, Post-Traumatic
Intervention type Behavioral, Drug
Interventions Fluoxetine, EMDR
Start date Jan 1, 1999
Completion Dec 1, 2003
First posted Nov 3, 1999
Last update posted Feb 20, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies